These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. (18)F-FDG and (18)F-FLT PET/CT imaging in the characterization of mediastinal lymph nodes. Rayamajhi SJ; Mittal BR; Maturu VN; Agarwal R; Bal A; Dey P; Shukla J; Gupta D Ann Nucl Med; 2016 Apr; 30(3):207-16. PubMed ID: 26661845 [TBL] [Abstract][Full Text] [Related]
10. (18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease. Asabella AN; Cimmino A; Altini C; Notaristefano A; Rubini G Hell J Nucl Med; 2011; 14(3):311-2. PubMed ID: 22087457 [TBL] [Abstract][Full Text] [Related]
11. A Case of Mediastinal Leiomyosarcoma Demonstrated on FDG PET/CT Imaging. Wu X; Huang Y; Li Y; Wang H; Jiang L Clin Nucl Med; 2019 Mar; 44(3):e158-e160. PubMed ID: 30624267 [TBL] [Abstract][Full Text] [Related]
12. 18F-FDG uptake on PET in primary mediastinal non-thymic neoplasm: a clinicopathological study. Kaira K; Abe M; Nakagawa K; Ohde Y; Okumura T; Takahashi T; Murakami H; Shukuya T; Kenmotsu H; Naito T; Hayashi I; Oriuchi N; Endo M; Kondo H; Nakajima T; Yamamoto N Eur J Radiol; 2012 Sep; 81(9):2423-9. PubMed ID: 22055682 [TBL] [Abstract][Full Text] [Related]
13. The Potential Utility of 18 F-FDG PET/CT in Monitoring Corticosteroid Therapy in Inflammatory Pseudotumor. Sicilia Pozo MLN; García Zoghby L; López de la Osa García A; Sotillo Sánchez R; Poblete García VM Clin Nucl Med; 2024 Mar; 49(3):e115-e117. PubMed ID: 38271259 [TBL] [Abstract][Full Text] [Related]
15. Paraneoplastic pemphigus as a first sign of metastatic retroperitoneal inflammatory myofibroblastic tumor: (18)F-FDG PET/CT findings. Dhull VS; Passah A; Rana N; Arora S; Mallick S; Kumar R Rev Esp Med Nucl Imagen Mol; 2016; 35(4):260-2. PubMed ID: 26740314 [TBL] [Abstract][Full Text] [Related]
16. (18)F-FDG PET/CT, cytoreductive surgery and intraperitoneal chemohyperthermia for the therapeutic management in peritoneal carcinomatosis: A pilot study. Cistaro A; Cucinotta M; Cassalia L; Priola A; Priola S; Pappalardo M; Coppolino P; De Simone M; Quartuccio N Rev Esp Med Nucl Imagen Mol; 2016; 35(4):232-7. PubMed ID: 26907833 [TBL] [Abstract][Full Text] [Related]
18. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer. Chang HT; Hu C; Chiu YL; Peng NJ; Liu RS PLoS One; 2014; 9(12):e115127. PubMed ID: 25517451 [TBL] [Abstract][Full Text] [Related]
19. [The role of whole body 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the management of unknown primary tumors]. Wu ZJ; Zhang YX; Wei H; Jia Q Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2253-6. PubMed ID: 18001544 [TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of 2-[(18)F] Fluoro-2-deoxy-D-glucose Positron Emission Tomography-Computed Tomography Scan Carried out During and After Radiation Therapy for Head and Neck Cancer Using Visual Therapy Response Interpretation Criteria. Min M; Lin P; Lee M; Ho Shon I; Lin M; Forstner D; Tieu MT; Chicco A; Bray V; Fowler A Clin Oncol (R Coll Radiol); 2016 Jun; 28(6):393-401. PubMed ID: 26782837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]